Summary:
A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder
Qualified Participants Must:
Male or female outpatients, 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and travel